Peptide drug screening is an evolving field, and as more research emerges, the detection of peptides will continue to improve
There are currently plenty of animal studies but very few, if any, BPC-157 human trials
Brubaker says drugs need to be carefully tested in stages before they are approved for use in people
Tolerability (human reports): Small uncontrolled reports describe NAD+ infusions as generally tolerated, with dose-related flushing and GI effects
Among the top five science-backed benefits one can expect with therapeutic use of BPC 157: Rapid repair & tissue regeneration: A 2021 study published in Frontiers in Pharmacology found that BPC 157 significantly accelerated wound healing, helping tissue bounce back by increasing blood flow and by ramping up collagen repairtwo must-haves when it comes to healing well
Source: Intranasal Delivery of Proteins and Peptides in the Treatment of Neurodegenerative Diseases (2015) Claim 3: Suppression of MYC target genes and oxidative phosphorylation are features of longevity-associated interventions